Latest News

オカダアイヨン 2027年3月期第1四半期決算ディープダイブ:一時的な需要減退を越え、圧倒的国内シェアと新中計「Onyx」で描く中長期成長ロードマップ
1. 2027年3月期 第1四半期 決算概要と業績サマリー オカダアイヨン株式会社の2027年3月期 第1四半期(1Q)連結業績は、売上高が59億78百万円

Yamabiko (6250) Q2 FY2026 Earnings Deep Dive: Strong Growth in North America and Europe, Full-Year Guidance Upward Revision, and Dividend Hike
1. Executive Summary Yamabiko Corporation (Ticker: 6250), a global manufacturer

Core Concept Technologies FY2026 Q2 Earnings Deep Dive: Double-Digit Revenue Growth Driven by DX Support and Accelerated Large-Scale Manufacturing Solutions
Core Concept Technologies FY2026 Q2 Earnings Deep Dive This report provides a detaile

Dynapac H1 FY2026 Earnings Analysis: Record-High Profits, Significant Full-Year Guidance Upgrade, and Early Achievement of Mid-Term Management Plan
1. Earnings Highlights: Record-High Profits and Significant Full-Year Guidance Upgra

Fujisan Magazine Service (3138) Q2 FY2026 Earnings Deep Dive: The 'Three Arrows' of Structural Transformation and Future Outlook
Executive Summary Fujisan Magazine Service Co., Ltd. (Tokyo Stock Exchange Growth: 3

Invincible Investment Corporation: Fiscal Period Ended June 2026 Earnings Analysis – Portfolio Resilience Amidst Post-Expo Headwinds and Growth Strategy Toward DPU of Over ¥4,500 by 2029
Executive Summary Invincible Investment Corporation (Ticker: 8963) is a diversif

GSI Creos Q1 FY2027 Earnings Analysis: Record-High Q1 Performance Driven by Mid-Term Plan Execution and Robust Shareholder Returns
Introduction GSI Creos Corporation (TSE Prime: 8101) has released its financial

SEED Co., Ltd. (7743) Q1 FY2027 Earnings Deep Dive: A Growth Roadmap Driven by Value-Added Products and Optimized Production
In the first quarter (Q1) of the fiscal year ending March 31, 2027, SEED Co., Ltd. maint

J.E.T. Co., Ltd. H1 FY2026 Earnings Analysis and Business Restructuring: Recap of Restatements, Performance Progress, and Growth Strategy Toward 2033
Introduction J.E.T. Co., Ltd. (Securities Code: 6228), a manufacturer of semiconduc

アビスト 2026年9月期第3四半期 決算ディープダイブ:単価改善と高稼働が牽引する高進捗、中計目標達成に向けた成長シナリオ
株式会社アビスト(証券コード:6087)は、自動車分野を中心とする機械設計およびシステム開発を手掛ける技術ソリューション企業です。同社が発表した2026年9月期第3四半期(

Hoover Brain Maintains Double-Digit Growth in Core Business and Revises Full-Year Outlook Upward: Deep Dive into Mid-to-Long-Term Strategy as an 'AI Guardian' and Q1 FY2027 Results
1. Executive Summary Hoover Brain Co., Ltd. (TSE Standard: 3927) reported its Q1

Syncray Co., Ltd. FY2026 Interim Earnings Deep Dive: A Growth Story Driven by Profitability Gains and Surging Order Backlogs
Syncray Co., Ltd. (Securities Code: 1724) delivered a highly robust performance in its

Takasho (7590) Latest Earnings: Operating Profit Up 1.0% YoY to 386 Million Yen, Net Income Jumps 50.7%
Takasho (7590) has released its latest financial results, reporting net sales of 11,098 million yen, representing a 1.5% increase year-on-year. Operating profit rose 1.0% to 386 million yen, while ord

Zero Co., Ltd. FY2026 Earnings Report: Record-High Revenue and Operating Profit, Evolution into an Automotive Logistics Infrastructure Provider, and Outlook for Continued Growth
Zero Co., Ltd. (Securities Code: 9028) has announced its financial results for the fisca

ナイル 2026年第2四半期決算ディープダイブ:増収基調と赤字幅縮小を継続、AI・教育領域の拡張とロールアップM&Aで描く持続的成長ストーリー
ナイル株式会社の2026年第2四半期決算は、主力の自動車産業DX事業の力強い成長とホリゾンタルDX事業の安定した収益貢献を両輪に、売上高が過去最高水準を更新し、

Magmag (4059) Q3 FY2026 Earnings Report: Maintaining Revenue Growth While Accelerating Upfront Investment in IP and Multi-Format Expansion
1. Executive Summary: Sustaining Revenue Growth Through Strategic Upfront Investment

Japan Excellent, Inc. 40th Fiscal Period Earnings Analysis: Accelerating Property Recycling and Rent Hikes to Drive Sustainable DPU Growth
Japan Excellent, Inc. (Ticker: 8987) has announced its financial results for the 40th fi

小野建 2027年3月期 第1四半期決算:鉄鋼スプレッド改善で本業堅調も、建設工事の遅延と販管費増が利益を圧迫
1. 2027年3月期 第1四半期 決算ハイライト 小野建株式会社(証券コード: 7414)の2027年3月期 第1四半期(2026年4月1日〜2026年6月30

Cyfuse Biomedical FY2026 Q2 Earnings Report: Revenue Surges 3.5x YoY; Clinical Trials Advance for Key 3D Regenerative Medicine Pipelines Including Peripheral Nerve and Osteochondral Regeneration
Executive Summary Cyfuse Biomedical K.K. (Securities Code: 4892), a developer of

【And Do Holdings】FY2026 Earnings Deep Dive: Navigating Portfolio Restructuring and Inventory Optimization Toward Accelerated Growth by 2030
1. FY2026 Earnings Summary and Overview of Structural Reform And Do Holdings Inc.